SCHEMBL13670329

SCHEMBL13670329

CC(C)NC(=O)c1cnc2c(c1)N(S(=O)(=O)c1ccc(Oc3ccccc3)cc1)CCO2

nearest known ligand 0.52

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CPT1A P50416 2/20 0.52
RORC P51449 5/20 0.46
NPC1 O15118 1/20 0.42
CYP2C9 P11712 1/20 0.42
LMNA P02545 3/20 0.40
KMT2A Q03164 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
CNR1 P21554 1/20 0.40
CNR2 P34972 1/20 0.40
BCL2L1 Q07817 1/20 0.39
MCL1 Q07820 1/20 0.39
HPGDS O60760 1/20 0.39
ALDH1A1 P00352 2/20 0.39
MMP9 P14780 1/20 0.38
MEN1 O00255 1/20 0.38
MAPT P10636 1/20 0.38
HTR6 P50406 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2004021 0.89 CPT1A (0.53) CPT1ARORCNPC1CYP2C9LMNA
SCHEMBL2005380 0.88 CPT1A (0.49) CPT1ARORCNPC1CYP2C9LMNA
SCHEMBL2001117 0.80 CPT1A (0.56) CPT1ARORCNPC1CYP2C9KMT2A
SCHEMBL2001102 0.79 CPT1A (0.56) CPT1ARORCNPC1CYP2C9HTR6
SCHEMBL12569922 0.79 CPT1A (0.54) CPT1ARORCNPC1CYP2C9LMNA
SCHEMBL2005194 0.79 CPT1A (0.53) CPT1ARORCCYP2C9CNR1CNR2
SCHEMBL2005198 0.79 CPT1A (0.53) CPT1ARORCCYP2C9CNR1CNR2
SCHEMBL2007284 0.78 CPT1A (0.52) CPT1ARORCCYP2C9KMT2AMCL1
SCHEMBL2000704 0.77 CPT1A (0.48) CPT1ARORCNPC1CYP2C9HPGDS
SCHEMBL2003367 0.77 CPT1A (0.52) CPT1ARORCNPC1CYP2C9HTR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009120660-A2 SUBSTITUTED PYRIDOXAZINES CARA THERAPEUTICS, INC. (US) 2009-10-01 WO disclosed